{"nct_id":"NCT00586651","title":"Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis","status":"COMPLETED","status_verified_date":"2015-09","start_date":"2007-12","start_date_type":null,"primary_completion_date":"2009-10","primary_completion_date_type":"ACTUAL","completion_date":"2010-09","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["TEVA"]}